Drug intelligence / Profile preview

NMRC-M3V-D-PfCAT

Development stage
Phase 1
Lead developer
Naval Medical Research Center
Modality
DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

NMRC-M3V-D-PfCAT is an investigational multicomponent plasmid DNA malaria vaccine developed by the Naval Medical Research Center as the DNA-prime component of the D/ChAd63-CAT heterologous prime-boost regimen. The blended vaccine encodes *Plasmodium falciparum* circumsporozoite protein, apical membrane antigen 1, and malaria multiple epitopes fused to thrombospondin-related adhesion protein. It is intended to induce cellular and humoral immune responses against pre-erythrocytic *P. falciparum* stages and was evaluated by intramuscular administration in a completed Phase 1 controlled human malaria infection study in malaria-naive adults. ([biotechhunter.com](https://biotechhunter.com/trials/NCT03341754))

Other names
D-CAT
02

Targets

CSP (Circumsporozoite protein)AMA1 (Apical membrane antigen 1)

Beyond the preview

Go deeper on NMRC-M3V-D-PfCAT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NMRC-M3V-D-PfCAT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call